Brian C Baumann
Overview
Explore the profile of Brian C Baumann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1004
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Apolo A, Baumann B, Al-Ahmadie H, Ballas L, Bangs R, Brothers K, et al.
Bladder Cancer
. 2025 Mar;
11(1):23523735251319185.
PMID: 40034245
The National Cancer Institute organized a virtual Clinical Trials Planning Meeting (CTPM) on 'Defining the next generation of clinical trials with combination therapies in non-muscle invasive bladder cancer (NMIBC)' led...
2.
Baumann B, Efstathiou J
Int J Radiat Oncol Biol Phys
. 2024 Oct;
121(3):737-740.
PMID: 39353476
No abstract available.
3.
McConkey D, Baumann B, Greenberg S, DeGraff D, Delacroix S, Efstathiou J, et al.
Bladder Cancer
. 2024 Jul;
10(1):1-8.
PMID: 38993535
No abstract available.
4.
Dastgheyb S, Dreyfuss A, LaRiviere M, Mohiuddin J, Baumann B, Shabason J, et al.
Adv Radiat Oncol
. 2024 Mar;
9(5):101456.
PMID: 38550376
Purpose: The purpose of this study was to evaluate the feasibility and safety of dose-escalated proton beam therapy for treating chordomas and chondrosarcomas of the skull base and spine. Methods:...
5.
Shaikh P, Som A, Deych E, Deng A, Reimers M, Baumann B, et al.
Clin Genitourin Cancer
. 2024 Feb;
22(2):586-592.
PMID: 38369389
Background: Cardiovascular (CV) disease is common among men with prostate cancer and the leading cause of death in this population. There is a need for CV risk assessment tools that...
6.
Maughan N, Zoberi J, Garcia-Ramirez J, Michalski J, Baumann B, Amurao M, et al.
Pract Radiat Oncol
. 2024 Feb;
14(5):457-463.
PMID: 38354977
Purpose: Radiopharmaceutical therapy (RPT) is a rapidly growing treatment modality. Though uncommon, patients may experience complications during their RPT treatment, which may trigger a rapid response from the hospital team....
7.
Benabdallah N, Lu P, Abou D, Zhang H, Ulmert D, Hobbs R, et al.
J Nucl Med
. 2023 Dec;
65(2):245-251.
PMID: 38124163
α-particle emitters are emerging as a potent modality for disseminated cancer therapy because of their high linear energy transfer and localized absorbed dose profile. Despite great interest and pharmaceutical development,...
8.
Waters M, Price A, Laugeman E, Henke L, Hugo G, Stowe H, et al.
Clin Transl Radiat Oncol
. 2023 Nov;
44:100693.
PMID: 38021093
Introduction: Stereotactic body radiation therapy (SBRT) is an emerging treatment modality for clinically localized prostate cancer (PCa). Online daily adaptive radiotherapy (ART) could potentially improve the therapeutic ratio of prostate...
9.
Anstadt E, Carmona R, Berlin E, Yegya-Raman N, Venigalla S, Reddy V, et al.
Cancer
. 2023 Oct;
130(3):476-484.
PMID: 37823514
Background: In select patients, pancreatic adenocarcinoma remains a local disease, yet there are no validated biomarkers to predict this behavior and who may benefit from aggressive local treatments. This study...
10.
Andruska N, Waters M, Fischer-Valuck B, Smith Z, Kim E, Reimers M, et al.
Clin Genitourin Cancer
. 2023 Sep;
21(6):653-659.e1.
PMID: 37704483
Background: Non-muscle invasive bladder cancer (non-MIBC) that is high-grade and confined to the lamina propria (HGT1) often has an aggressive clinical course. Currently, there is limited data on the comparative...